Skip to end of metadata
Go to start of metadata



Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva PetersJenaker Consultingx
Jean DuteauDuteau Designx
John HatemIndependent Consultantx
Scott Robertson Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile Digital Healthx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborative
Stephen ChuADHAx
Tim McNeilSurescripts
Kim RobertsPharmacy HIT Collaborative
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna
James Tcheng

Peter Muir

Joe KellySurescripts
Peter Jordan

Jose Costa Teixeira
Jeff ShickUSP
Kent BulzaArtera

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Proposals

Project Proposals in Review

  • Person Centric FHIR View - PSS-2153 - scope is unclear but Pharmacy doesn't need to be involved in the project. 

Project Scope Statements

Project Scope Statements

  • Influenza Hospitalization Surveillance Network -  PSS-2125 - 

External Meeting Review

Catalog Updates (John Hatem)

  • No meeting

Workflow Update (John Hatem)

  • No Pharmacy specific updates

Healthcare Product Update (John Hatem)

  • John to look at BDP Dispense Status

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)

  • Meeting to be held on Feb 1 - John and Scott attending - "Medication List Management and Reconciliation - 5pm Eastern
    • in Conference call schedule

Potential Drug-Drug Interaction (PDDI) CDS IG

  • no further action - remove from agenda

NCPDP Updates (NCPDP Members)

  • no calls this week due to NCPDP meetings this week
  • Digital Therapeutics push going on - looking to see who it could work in ambulatory care workflow

Pharmacist Consult Note (Scott)

  • Publication Request - not ready yet - waiting for NCPDP approval

Pharmacy Templates

  • Block Vote - dealt with at the WGM - Giorgio working on applying changes and then will bring forward a publication request

Specialty Medication Enrolment IG

  • Block Vote - block vote was posted
    • a couple of responses received - no one indicated there was an issue

    • Motion to approved proposed dispositions on the following items  - moved by Frank McKinney - seconded by John Hatem - 6-0-0 - Approved





Pre Applied


Describe specialty medication and reason for uninitiated

Floyd Eisenberg




Combine the task type code systems into one code system

Rob McClure

Persuasive with Modification



Clarify how a prescriber will know specific pieces of information

Celine Lefebvre

Not Persuasive


The Consent framework should be a reusable infrastructure element rather than being re-defined in domain-specific APIs/IGs

Ioana Singureanu

Not Persuasive


Include "count" parameter if one match response allowed

Carmela A. Couderc




Change "ID" to "IDs"

Carmela A. Couderc

Not Persuasive with Modification



Defining URL should be anchored in THO. 1.

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 2

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 3

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 4.

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 5.

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 6

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 7.

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 8

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 9

Joan Harper

Considered for Future Use


Defining URL should be anchored in THO. 10

Joan Harper

Considered for Future Use

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

  • Jean has a resource working on making the changes
    • working on MedUsage name change - 
    • Has assigned a number of issues to Rosemary
    • Feb 24 - all changes from ballot - then will be published as R5
    • 3 open issues not voted on

Any Other Business

  • Dosage Timing - Jose
    • timing.repeat.when - doesn't have between meals
    • this is a FHIR-I issues - related to FHIR-34124 
  • US Medication FHIR Implementation Guide - Jean will update to "Considered for Future Use" since IG was withdrawn
  • WGM Meeting Room Request
    • will be coming out - Co-chairs will watch for notice

Next meeting: